Letter: Metformin treatment and hepatocellular carcinoma risk in non-alcoholic fatty liver disease

dc.contributor.authorDoğru, Teoman
dc.contributor.authorKırık, Ali
dc.contributor.authorSönmez, Alper
dc.date.accessioned2020-01-23T10:04:35Z
dc.date.available2020-01-23T10:04:35Z
dc.date.issued2019en_US
dc.departmentFakülteler, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümüen_US
dc.descriptionDoğru, Teoman (Balikesir Author)en_US
dc.description.abstractÖzet yok.en_US
dc.identifier.doi10.1111/apt.15462
dc.identifier.endpage836en_US
dc.identifier.issn0269-2813
dc.identifier.issn1365-2036
dc.identifier.issue7en_US
dc.identifier.scopus2-s2.0-85072281974
dc.identifier.scopusqualityQ1
dc.identifier.startpage835en_US
dc.identifier.urihttps://doi.org/10.1111/apt.15462
dc.identifier.urihttps://hdl.handle.net/20.500.12462/10544
dc.identifier.volume50en_US
dc.identifier.wosWOS:000486518700021
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoenen_US
dc.publisherWileyen_US
dc.relation.ispartofAlimentary Pharmacology & Therapeuticsen_US
dc.relation.publicationcategoryDiğeren_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectInsulin-Resistanceen_US
dc.subjectFibrosisen_US
dc.titleLetter: Metformin treatment and hepatocellular carcinoma risk in non-alcoholic fatty liver diseaseen_US
dc.typeOtheren_US

Dosyalar

Lisans paketi

Listeleniyor 1 - 1 / 1
Yükleniyor...
Küçük Resim
İsim:
license.txt
Boyut:
1.44 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama: